Oppenheimer Sees Increased Clarity at Sequenom (SQNM)

Go back to Oppenheimer Sees Increased Clarity at Sequenom (SQNM)

Wedbush Downgrades Sequenom (SQNM) to Neutral

May 7, 2015 8:41 AM EDT

Wedbush downgraded Sequenom (NASDAQ: SQNM) from Outperform to Neutral with a price target of $4.50 (unchanged).

For an analyst ratings summary and ratings history on Sequenom click here. For more ratings news on Sequenom click here.

Shares of Sequenom closed at $4.47 yesterday.

... More

Sequenom (SQNM) Posts Q1 Profit of $0.12/Share

May 6, 2015 4:12 PM EDT

Sequenom (NASDAQ: SQNM) reported Q1 EPS of $0.12, which may note compare to the analyst estimate of ($0.03). Revenue for the quarter came in at $37.8 million versus the consensus estimate of $38.6 million.

The improvement in the net earnings from the prior year is... More